These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37830952)

  • 1. Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19.
    Rice E; Oakes DB; Holland C; Moore HC; Blyth CC
    Curr Opin Infect Dis; 2023 Dec; 36(6):522-528. PubMed ID: 37830952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RSV through the COVID-19 pandemic: Burden, shifting epidemiology, and implications for the future.
    Stein RT; Zar HJ
    Pediatr Pulmonol; 2023 Jun; 58(6):1631-1639. PubMed ID: 36811330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus infection in the modern era.
    Ludlow M
    Curr Opin Infect Dis; 2023 Jun; 36(3):155-163. PubMed ID: 36939556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions.
    Binns E; Tuckerman J; Licciardi PV; Wurzel D
    J Paediatr Child Health; 2022 Oct; 58(10):1741-1746. PubMed ID: 36073299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving Epidemiology of Pediatric Respiratory Syncytial Virus (RSV) Cases Around COVID-19 Pandemic: Impact and Clinical Insights, Retrospective Cohort Study.
    Gashgarey D; Alsuhaibani M; Alhuthil R; Alhabshan H; Alabdulqader A; Badran R; Balhmar A; Aldawood H; AlBanyan EA; AlGhamdi S; AlJumaah S; AlYabes O; Al-Hajjar S
    J Epidemiol Glob Health; 2024 Jun; 14(2):319-326. PubMed ID: 38573464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID-19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children.
    Lu Y; Chen Q; Ren S; Zhang Y; Yi L; Qian C; Shen J; Liu X; Jiang M; Wang B; Song J; Shao X; Zhang T; Tian J; Zhao G
    Influenza Other Respir Viruses; 2024 Apr; 18(4):e13291. PubMed ID: 38653953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential impact of COVID-19 non-pharmaceutical interventions on the epidemiological dynamics of respiratory syncytial virus subtypes A and B.
    Holmdahl I; Bents SJ; Baker RE; Casalegno JS; Trovão NS; Park SW; Metcalf JE; Viboud C; Grenfell B
    Sci Rep; 2024 Jun; 14(1):14527. PubMed ID: 38914626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis.
    Leija-Martínez JJ; Esparza-Miranda LA; Rivera-Alfaro G; Noyola DE
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in endemic patterns of respiratory syncytial virus infection in pediatric patients under the pressure of nonpharmaceutical interventions for COVID-19 in Beijing, China.
    Jiang ML; Xu YP; Wu H; Zhu RN; Sun Y; Chen DM; Wang F; Zhou YT; Guo Q; Wu A; Qian Y; Zhou HY; Zhao LQ
    J Med Virol; 2023 Jan; 95(1):e28411. PubMed ID: 36524893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.
    Li Y; Wang X; Blau DM; Caballero MT; Feikin DR; Gill CJ; Madhi SA; Omer SB; Simões EAF; Campbell H; Pariente AB; Bardach D; Bassat Q; Casalegno JS; Chakhunashvili G; Crawford N; Danilenko D; Do LAH; Echavarria M; Gentile A; Gordon A; Heikkinen T; Huang QS; Jullien S; Krishnan A; Lopez EL; Markić J; Mira-Iglesias A; Moore HC; Moyes J; Mwananyanda L; Nokes DJ; Noordeen F; Obodai E; Palani N; Romero C; Salimi V; Satav A; Seo E; Shchomak Z; Singleton R; Stolyarov K; Stoszek SK; von Gottberg A; Wurzel D; Yoshida LM; Yung CF; Zar HJ; ; Nair H;
    Lancet; 2022 May; 399(10340):2047-2064. PubMed ID: 35598608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonality, molecular epidemiology, and virulence of Respiratory Syncytial Virus (RSV): A perspective into the Brazilian Influenza Surveillance Program.
    Vianna LA; Siqueira MM; Volpini LPB; Louro ID; Resende PC
    PLoS One; 2021; 16(5):e0251361. PubMed ID: 34003843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France.
    Fourgeaud J; Toubiana J; Chappuy H; Delacourt C; Moulin F; Parize P; Scemla A; Abid H; Leruez-Ville M; Frange P
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2389-2395. PubMed ID: 34347190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa.
    Bents SJ; Viboud C; Grenfell BT; Hogan AB; Tempia S; von Gottberg A; Moyes J; Walaza S; Hansen C; Cohen C; Baker RE
    Influenza Other Respir Viruses; 2023 Dec; 17(12):e13229. PubMed ID: 38090227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global molecular diversity of RSV - the "INFORM RSV" study.
    Langedijk AC; Lebbink RJ; Naaktgeboren C; Evers A; Viveen MC; Greenough A; Heikkinen T; Stein RT; Richmond P; Martinón-Torres F; Nunes M; Hosoya M; Keller C; Bauck M; Cohen R; Papenburg J; Pernica J; Hennus MP; Jin H; Tabor DE; Tovchigrechko A; Ruzin A; Abram ME; Wilkins D; Wildenbeest JG; Kragten-Tabatabaie L; Coenjaerts FEJ; Esser MT; Bont LJ
    BMC Infect Dis; 2020 Jun; 20(1):450. PubMed ID: 32591017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time trend and seasonality in medically attended respiratory syncytial virus (RSV) infections in US children aged 0-5 years, January 2010-January 2023.
    Wang L; Berger N; Davis PB; Kaelber DC; Volkow N; Xu R
    Fam Med Community Health; 2023 Oct; 11(4):. PubMed ID: 37844966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Nonpharmaceutical Interventions Implemented in Response to the COVID-19 Pandemic on Seasonal Respiratory Syncytial Virus: Analysis of Google Trends Data.
    Ravkin HD; Yom-Tov E; Nesher L
    J Med Internet Res; 2022 Dec; 24(12):e42781. PubMed ID: 36476385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes following the Onset of the COVID-19 Pandemic in the Burden of Hospitalization for Respiratory Syncytial Virus Acute Lower Respiratory Infection in Children under Two Years: A Retrospective Study from Croatia.
    Mrcela D; Markic J; Zhao C; Viskovic DV; Milic P; Copac R; Li Y
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022.
    Mohebi L; Karami H; Mirsalehi N; Ardestani NH; Yavarian J; Mard-Soltani M; Mokhatri-Azad T; Salimi V
    J Med Virol; 2022 Dec; 94(12):5802-5807. PubMed ID: 35961780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human respiratory syncytial virus and influenza seasonality patterns-Early findings from the WHO global respiratory syncytial virus surveillance.
    Chadha M; Hirve S; Bancej C; Barr I; Baumeister E; Caetano B; Chittaganpitch M; Darmaa B; Ellis J; Fasce R; Kadjo H; Jackson S; Leung V; Pisareva M; Moyes J; Naguib A; Tivane A; Zhang W;
    Influenza Other Respir Viruses; 2020 Nov; 14(6):638-646. PubMed ID: 32163226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: Association with school closures.
    Billard MN; van de Ven PM; Baraldi B; Kragten-Tabatabaie L; Bont LJ; Wildenbeest JG
    Influenza Other Respir Viruses; 2022 Sep; 16(5):926-936. PubMed ID: 35733362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.